Sorrento Therapeutics Investor
Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.
Total Funding:
264418495.0
Acquisitions Number:
Made Acquisitions
Headquarters:
San Diego, California, United States
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$1M to $10M
Investment Stage:
N/A
Last Funding Type:
Post-IPO Equity
Number Of Exists:
N/A
Technology:
Others
Investor Type:
N/A
Last Funding Date:
2019-10-09
Investors Number:
1
Founded Date:
2006-01-01
Industry:
PharmTech